… COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2…
to generate a binary and co-complex SARS-CoV-2–human protein–protein interactome …

… Natural products hold a prominent role in discovering novel therapeutics to mitigate the
current COVID-19 pandemic; however, further investigations regarding in vitro, in vivo, pre-…

… Now, we have the seventh CoV as SARS-CoV-2 whose couple of strains have been …
respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (…

… features of COVID-19 caused by SARS-CoV-2 variants (… therapies in an attempt to
provide better preventive and treatment strategies for COVID-19 caused by different SARS-CoV-2 …

… coronavirus 2 (SARS-CoV-2) and efforts to develop diagnostic, prophylactic, and therapeutic
responses to COVID-19. We … in understanding and responding to the COVID-19 pandemic. …

… coronavirus 2 (SARS‐CoV‐2) by the coronavirus study … as coronavirus disease (COVID‐19).
A month later, March 11, 2020, the WHO declared COVID-19 a pandemic, and SARS-CoV-2 …

… relate to mortality following SARS-CoV-2 infection. As an additional aim, we tested whether
type of … therapy received prior to COVID-19 and provision of SARS-CoV-2–specific therapy …

… coronavirus 2 (SARS-CoV-2)-specific virulence factors has greatly hampered the therapeutic
management of patients with coronavirus … therapeutic approaches against COVID-19, we …

… of SARS-CoV-2 with its cellular receptor angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 …
Also, interaction of the SARS-CoV-2 with the PRRs is instrumental in inducing cytokine, …

… Even while SARS-CoV-2 predominantly affects the … since the beginning of the SARS-CoV-2
pandemic, including the … treatments for the treatment of COVID-19 are discussed in this work. …